Alimera Sciences (ALIM) CEO Eiswirth received 14,700 Restricted Stock Units
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Richard S Eiswirth Jr (President and CEO at Alimera Sciences Inc., ALIM) reported that they received 14,700 Restricted Stock Units on Mar 11, 2024.
- Reporting person
- Eiswirth Richard S Jr
- Role
- President and CEO
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 11, 2024 | Grant or award (A) | Restricted Stock UnitsOn 14,700 Common Stock1, 2 | +14,700 | - | - | 14,700 direct |
Holdings before and after
- Restricted Stock Units: 0 to 14,700 direct
Footnotes from the filing
- 1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one (1) share of the common stock of the Issuer.
- 2. The RSUs were awarded to the Reporting Person under the Alimera Sciences, Inc. 2023 Equity Incentive Plan. 25% of the RSUs are scheduled to vest on the first anniversary of the Reporting Person's vesting start date of May 20, 2024 and the remaining portion of the RSUs will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous employment with the Issuer on each such vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Eiswirth report in this ALIM Form 4?
Richard S Eiswirth Jr (President and CEO at Alimera Sciences Inc., ALIM) reported that they received 14,700 Restricted Stock Units on Mar 11, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ALIM
Earlier insider filings at ALIM
- Mar 14, 2024SEC Form 4 filed by Ashman Philip
- Mar 14, 2024SEC Form 4 filed by Maltz Elliot
- Jan 11, 2024Ashman Philip covered exercise/tax liability with 2,938 shares, decreasing direct ownership by 2% to 130,377 units (SEC Form 4)
- Jan 4, 2024SEC Form 4 filed by Maltz Elliot
- Dec 13, 2023SEC Form 4 filed by Wood Todd Michael
Quantisnow market dataNASDAQ
ALIM
Alimera Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2010
Get push alerts for ALIM
Full ALIM profile on Quantisnow Follow ALIM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time